Generic Pharmasec said that it has signed an agreement with Abbott Point of Care (APOC) for the distribution, marketing, and promotion of the latter’s full variety of products in India.

Abbott Point of Care is the medical and diagnostics devices unit of Abbott.

Generic Pharmasec said that the agreement will increase the annual diagnostic tests supplied by the company by more than two-fold to up to a million tests annually.

The Mumbai-based company said that it will now increase its concentration on creating high value propositions for all hospitals across India for all their critical diagnostic needs.

To boost its presence in India and enhance access to critical diagnostic solutions in tier-2 and tier-3 towns, Generic Pharmasec will appoint 15 new sub-distributors over next 24 months in such identified towns.

Generic Pharmasec stated: “We aim to increase i-STAT devices penetration by at least 1,000 additional hospital set-ups in the next 24 months by creating long-term strategies for Marketing & Promotion with this unique partnership with Abbott Point of Care Inc.”

  Abbott, Abbott Point of Care, Generic Pharmasec, India, Mumbai